TELOMERE LOSS IN PH - NEGATIVE CHRONIC MYELOPROLIFERATIVE NEOPLASMS: THE ROLE OF JAK2 V617F MUTATION ALLELE BURDEN AND THE INFLUENCE OF THE HISTORY OF THE ILLNESS

被引：0
|
作者：
Ruella, M. [1 ]
Salmoiraghi, S. [2 ]
Risso, A.
Carobbio, A. [2 ]
Sivera, P. [3 ]
Mezzabotta, M. [3 ]
Ricca, I. [4 ]
Barbui, T. [2 ]
Tarella, C. [3 ]
Rambaldi, A. [2 ]
机构：
[1] Univ Turin, Turin, Italy
[2] Ospedali Riuniti Bergamo, Bergamo, Italy
[3] ASO Mauriziano, Turin, Italy
[4] AO Cottolengo, Turin, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0403
引用
收藏
页码：164 / 164
页数：1
相关论文
共 50 条
  • [1] JAK2 V617F ALLELE BURDEN IN CHRONIC MYELOPROLIFERATIVE DISEASES
    Skerget, Matevz
    Pajic, Tadej
    Kralj, Eva
    Vuckovic, Josko
    ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL, 2008, 77 : I57 - I61
  • [2] New advances in the role of JAK2 V617F mutation in myeloproliferative neoplasms
    Zhang, Yongchao
    Zhao, Yue
    Liu, YuSi
    Zhang, Minyu
    Zhang, Jihong
    CANCER, 2024, 130 (24) : 4229 - 4240
  • [3] JAK2 V617F Mutation Allele Burden (MAB) and Its Correlation with Hematologic Characteristics in Myeloproliferative Neoplasms
    Kim, David Y.
    Tariq, Hamza
    Brown, Alan F.
    Vadlamudi, Kumari
    Wang, Yao
    Ikoma, Shohei
    Holder, Kenneth N.
    Higgins, Russell A.
    Fan, Hongxin
    BLOOD, 2017, 130
  • [4] JAK2 V617F mutation detection in chronic myeloproliferative neoplasms by digital PCR
    Waterhouse, M.
    Pfeifer, D.
    Follo, M.
    Bertz, H.
    Finke, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 196 - 196
  • [5] Low JAK2 V617F Allele Burden in Ph-Negative Chronic Myeloproliferative Neoplasms Is Associated with Additional CALR or MPL Gene Mutations
    Makarik, Tatiana, V
    Abdullaev, Adhamjon O.
    Nikulina, Elena E.
    Treglazova, Svetlana A.
    Stepanova, Elena E.
    Subortseva, Irina N.
    Kovrigina, Alla M.
    Melikyan, Anait L.
    Kulikov, Sergei M.
    Sudarikov, Andrey B.
    GENES, 2021, 12 (04)
  • [6] Correlation of JAK2 V617F Mutation Burden with Clinical and Hematologic Characteristics of Myeloproliferative Neoplasms
    Brown, A. F.
    Wang, Y.
    Abu-Ghusson, M. M.
    George, P. A.
    Vadlamudi, K.
    Furmaga, W. B.
    Fan, H.
    MODERN PATHOLOGY, 2013, 26 : 321A - 321A
  • [7] Correlation of JAK2 V617F Mutation Burden with Clinical and Hematologic Characteristics of Myeloproliferative Neoplasms
    Brown, A. F.
    Wang, Y.
    Abu-Ghusson, M. M.
    George, P. A.
    Vadlamudi, K.
    Furmaga, W. B.
    Fan, H.
    LABORATORY INVESTIGATION, 2013, 93 : 321A - 321A
  • [8] IMPACT OF THE JAK2 (V617F) MUTATION AND THE MUTANT ALLELE BURDEN ON DISEASE PROGRESSION IN CHRONIC MYELOPROLIFERATIVE DISORDERS
    Passamonti, F.
    Rumi, E.
    Pietra, D.
    Boveri, E.
    Pascutto, C.
    Lazzarino, M.
    Cazzola, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 298 - 299
  • [9] The JAK2 V617F Allele Burden in Latent Myeloproliferative Neoplasms Presenting with Splanchnic Vein Thrombosis
    Goodyer, Matthew
    Langabeer, Stephen E.
    Haslam, Karl
    Murphy, Karen
    PATHOLOGY & ONCOLOGY RESEARCH, 2016, 22 (01) : 229 - 230
  • [10] The JAK2 V617F mutation in Philadelphia-negative chronic myeloproliferative disorders
    Stoj, Anastazja
    Rudzki, Zbigniew
    Stachura, Jerzy
    Sacha, Tomasz
    Czekalska, Sylwia
    JOURNAL OF CLINICAL PATHOLOGY, 2007, 60 (09) : 1070 - 1071
12345